(Q44122811)

30 November 2017

Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis (English)

1 reference

30 November 2017

1 reference

meglumine antimoniate

1 reference

Iraj Esfandiarpour

1

1 reference

PubMed ID

12207774

30 November 2017

Afsáneh Alavi

series ordinal

2

1 reference

PubMed ID

12207774

30 November 2017

language of work or name

1 reference

1 August 2002

1 reference

International Journal of Dermatology

30 November 2017

1 reference

30 November 2017

41

1 reference

30 November 2017

8

1 reference

30 November 2017

521-524

1 reference

Epidemiology of cutaneous leishmaniasis in the Isfahan province of Iran

30 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01526.X

Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01526.X

Oriental sore. A look at trends in and approaches to the treatment of leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01526.X

Treatment of recurrent cutaneous Leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01526.X

Pyrazolopyrimidine metabolism in the pathogenic trypanosomatidae

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01526.X

Antileishmanial action of 4-thiopyrazolo (3.4-d) pyrimidine and its ribonucleoside. Biological effects and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01526.X

10.1046/J.1365-4362.2002.01526.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference

PubMed ID

12207774